Nasdaq Profile (ISPC) Is A Low Float (Under 1Mn Shares) Past Champ Back On My Radar

Hot off two breakout ideas, it's time to focus up quickly. *Sponsored Nasdaq Profile (ISPC) Is A Low Float (Under 1Mn Shares) Past Champ Back On My Radar [Yahoo Finance]( Reports Incredibly Low Float Of 543.21k Shares! November 7th Dear Reader, Hot off two breakout ideas, it's time to focus up quickly. This past week, I brought two different profiles to your attention for radar consideration. My Halloween morning profile took a moment to heat up, but went on an intraday surge in need of note. Running from an open of $.065 to a high of $.074, that Nasdaq idea popped approximately 13% intraday. A solid appetizer, but the main course came on Friday. My November kick-off profile caught the breakout bug as it ran from a previous night's after hours close of $.435 all the way to a high of $.6702 one day later. The resulting explosion of approximately 54% put that NYSE American profile in the recent champ category and had use focusing on a new breakout idea. Popping-off with a move of approximately 66% intraday when I previously suggested it as a radar watch, this past champ displayed explosive potential. And when you see [this profile's float]( (under 1Mn shares), you'll understand why it again has top place on our watch-list going into Thursday's opening bell. Drop what you're doing and consider putting this Nasdaq profile on your radar: *iSpecimen Inc. (Nasdaq: ISPC)* iSpecimen offers an online marketplace for human biospecimens, connecting scientists in commercial and non-pro-fit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. And several potential catalysts could create breakout buzz for ISPC. Check them out: #1. - A Very Low Float Could Create A Volatile Scenario In Moments. #2. - An Explosive Chart History Since Mid-September Needs To Be Taken Seriously. #3. - Major Revenue Growth Announced For Q2 2024 (Increase of 76% YOY). #4. - This Company Displays A Long Growth History That's Been Picking Up The Pace In Recent Years... But more on those in a second... Company Breakdown: iSpecimen Inc. (Nasdaq: ISPC) iSpecimen was founded to address a critical challenge: how to efficiently connect life science researchers who need human biospecimens with the billions of specimens available in healthcare organizations worldwide. Their ground-breaking iSpecimen Marketplace® aids in solving this problem, reinventing the biospecimen procurement process to help accelerate medical discovery. Biospecimens are Essential for Life Science R&D Biospecimen Supply Chain Challenges Providers miss revenue and research opp's > 1 Billion Patient - encounters yearly in the U.S. where a specimen could be provided for research > 3 Billion - clinical specimens are discarded annually worldwide > 800 Million - banked specimens are in biorepository inventories worldwide Researchers limit their work 10 years ago, 81% - of researchers said they limit the scope of their work due to difficulties obtaining biospecimens … in 2022, 78% - of researchers said they find it difficult-to-extremely difficult to find the type and quantity of specimens they need “Challenging” and “Inefficient” - most common words used to describe biospecimen procurement process by researchers ----- iSpecimen Marketplace | Approach Key iSpecimen Inc. (Nasdaq: ISPC) Highlights - Similar to Amazon, iSpecimen has developed an online marketplace to seamlessly connect researchers with healthcare providers and supplier organizations. - First mover advantage that addresses an inefficient and fragmented global biospecimen supply chain that is poised to be disrupted by an online solution. - $3Bn-$4Bn global biospecimen market growing at 10-15% per year. - Strong revenue growth with an 8-year CAGR of 39% fueled by precision and regenerative medicine research. - Plans to enhance existing platform and develop new service offering to increase revenue opp's. Grab Key Sources Here: [ISPC Presentation.]( [ISPC Website.]( ----- As mentioned above, (Nasdaq: ISPC) has several potential catalysts going for it right now. Take a look: #1. ISPC Potential Catalyst - A Very Low Float Could Create A Volatile Scenario In Moments. According to info from the [Yahoo Finance website]( ISPC has an extremely low float. In fact, the website reports this profile to have approximately 543.21k shares in its float. Why is that important? It's important on one crucial level. Volatility. Could more positive company news towards the end of 2024 provide a near term spark? ----- #2. ISPC Potential Catalyst - An Explosive Chart History Since Mid-September Needs To Be Taken Seriously. In the last two months, ISPC has been a spiker. Check this out: Here's a quick list of explosive moves: 1. 9/16/24 - From a low of $3.41, ISPC climbed to a high of $6.60 two days later for a run of 93%. 2. 9/20/24 - Bottoming at a low of $4.13, ISPC leaped to a high of $6.25 one session later for a surge of 51%. 3. 10/18/24 - Erupting from an open of $4.11, ISPC exploded to a high of $8.30 the following session for a mind-blowing 101% move. 4. 10/30/24 - Bouncing from a low of $3.41, ISPC popped to a high of $5.48 within a week for a run of 60%. Knowing (Nasdaq: ISPC) has a very low float, could another major move be in the cards ahead of 2025? ----- #3. ISPC Potential Catalyst - Major Revenue Growth Announced For Q2 2024 (Increase of 76% YOY). iSpecimen Reports Second Quarter 2024 Results Revenue increased 76% year-over-year to approximately $2.86Mn Brielan Smiechowski Named SVP of Sales and Business Development LEXINGTON, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three and six month periods ended June 30, 2024. “iSpecimen’s strong results reflect the progress we have made towards operational improvements throughout the Company this year, resulting in a 76% increase in revenue to $2.86Mn for the second quarter of 2024,” stated Tracy Curley, CEO of iSpecimen. “The initiatives we have completed, namely, our Next Day Quotes program, has quickly become a key focus internally for our business and has meaningfully improved our conversion rates throughout the first half of 2024. In addition, our Supplier Refresh program has allowed us to engage with our suppliers at a level not previously possible, which in turn, has contributed to increased velocity through our sales funnel and the strong results we generated for the quarter. We also continued to decrease costs through head count and other expense reductions, as we focus on driving towards pro-fit-ability and increasing shareholder value.” ... [Read the full article here.]( ----- #4. ISPC Potential Catalyst - This Company Displays A Long Growth History That's Been Picking Up The Pace In Recent Years... iSpecimen Inc. has been growing with leaps and bounds. Take a look at the [company's evolution]( What could the next decade hold for (Nasdaq: ISPC)? ----- RECAP: 4 Key Potential Catalysts Backing (Nasdaq: ISPC) #1. - A Very Low Float Could Create A Volatile Scenario In Moments. #2. - An Explosive Chart History Since Mid-September Needs To Be Taken Seriously. #3. - Major Revenue Growth Announced For Q2 2024 (Increase of 76% YOY). #4. - This Company Displays A Long Growth History That's Been Picking Up The Pace In Recent Years... ----- Coverage is officially initiated on iSpecimen Inc. (Nasdaq: ISPC). I'll be in touch with updates moving forward. Talk soon. Sincerely, FierceAnalyst | Jaks Swift Editorial Writer (Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.) *FierceInvestor (FierceInvestor . com) is owned by SWN Media LLC, a limited liability company. Data is provided from third-party sources and FierceInvestor (FI) is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized fin.ancial advice, are not finan.cial advisors, and our opinions are not suitable for all in.vest.ors. The single member of SWN Media LLC owns and operates smallcapfirm . com (“SCF”), stockwirenews . com (“SWN”), and stockstreetwire . com ("SSW"). From time to time, SWN, SCF, FI, and/or SSW will publicly disseminate information about a company via website, email, SMS and other points of media. Please see important disclosure information here: [( Pursuant to an agreement between SWN Media LLC and TD Media LLC, SWN Media LLC has been hired by TD Media LLC for a period beginning on 11/06/2024 and ending on 11/07/2024 to publicly disseminate information about (ISPC:US) via digital communications. Under this agreement, SWN Media LLC has been paid seventeen thousand five hundred USD (“Funds”) to disseminate information about (ISPC:US) via digital communications. These Funds were part of the funds that TD Media LLC received from a third party who did not receive the funds from the issuer and does not own st.ock in the issuer but the reader should assume that the clients of the third party own shares in the issuer that they will liquidate at or near the time you receive this communication, which has the potential to hurt share prices. Neither SWN Media LLC or its member own shares of (ISPC:US). The single member of SWN Media LLC is also the single member of TD Media LLC. Pursuant to an agreement between TD Media LLC and IR Agency LLC, TD Media LLC has been hired for a period beginning on 11/06/2024 and ending on 11/07/2024 to publicly disseminate information about (ISPC:US) via digital communications. Under this agreement, TD Media LLC has been paid seventy-five thousand USD (“Funds”). These Funds were part of the funds that TD Media LLC received from a third party who did not receive the funds from the issuer and does not own st.ock in the issuer but the reader should assume that the clients of the third party own shares in the issuer that they will liquidate at or near the time you receive this communication, which has the potential to hurt share prices. Neither TD Media LLC or its member own shares of (ISPC:US). [( Fierce | 4834 NW 2nd Ave Unit #388 | Boca Raton, FL 33431 US [Unsubscribe]( | [Update Profile]( | [Constant Contact Data Notice](